Ftse Mib
34.571,62
-0,30%
DAX
19.147,85
-0,54%
S&P 500
5.712,69
-0,28%
NASDAQ
18.179,98
-0,33%
Bitcoin
67.515,69
-1,78%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Scinai Immunotherapeutics Ltd (SCNI) Scinai Immunotherapeutics Ltd (SCNI) Notizie

Scinai Immunotherapeutics Ltd

SCNI
3,65
0,09 (2,53%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:05:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/10/202411:59PRNUSScinai Leadership to Showcase Company's cGMP Biologics CDMO..
15/10/202421:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202418:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202413:00PRNUSScinai to Host Online Expert Panel on Plaque Psoriasis..
09/9/202417:12GLOBEIBN Announces Latest Episode of The BioMedWire Podcast..
09/9/202413:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202412:31PRNUSScinai Regains Full Compliance with Nasdaq Listing..
29/8/202412:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/8/202415:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/8/202414:45PRNUSScinai Announces Closing of Loan Restructuring Agreement..
20/8/202421:06EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
20/8/202417:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202415:30PRNUSScinai Announces Entering into $2 Million Private Equity..
15/8/202413:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202413:00PRNUSScinai Publishes Q2 2024 Financial Results and Provides..
13/8/202423:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/8/202413:00PRNUSScinai Announces Signing of Loan Restructuring Agreement..
12/8/202420:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202420:19EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
05/8/202423:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/7/202413:00PRNUSScinai Immunotherapeutics Announces Positive Regulatory..
15/7/202417:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/7/202417:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/7/202413:00PRNUSScinai Immunotherapeutics Announces promising results in an..
08/7/202423:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202418:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202418:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202414:14PRNUSScinai Immunotherapeutics Announces Receipt of an Updated..
03/7/202415:32PRNUSScinai Immunotherapeutics Granted Extension by Nasdaq..
02/7/202414:12PRNUSScinai Publishes Q1 2024 Financial Results and Provides..
14/6/202413:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/6/202416:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/6/202416:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/6/202413:00PRNUSScinai Immunotherapeutics Announces Receipt of a Letter of..
07/6/202413:00PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq..
28/5/202420:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202422:01PRNUSScinai Immunotherapeutics Announces Receipt of a Nasdaq..
16/5/202419:49EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/5/202423:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202422:01PRNUSScinai Publishes FY 2023 Financial Statements, Files Annual..
07/5/202416:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/5/202415:21PRNUSScinai Immunotherapeutics Announces Receipt of Nasdaq..
10/4/202413:00PRNUSScinai to showcase its novel biological local therapeutic..
08/4/202423:15APSBiotech Rips Following Five-Year Master Service Agreement..
08/4/202413:00PRNUSScinai Immunotherapeutics' CDMO Unit Selected by Ayana..
12/3/202413:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
29/2/202414:45PRNUSScinai to showcase its cGMP biologics CDMO and innovative..
13/2/202413:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development..
30/1/202422:19EDGAR2Form F-3 - Registration statement by foreign private issuers
25/1/202416:26PRNUSScinai Immunotherapeutics Congratulates its Co-Lead..
Apertura: 3,56 Min: 3,56 Max: 3,6808
Chiusura: 3,56

La tua Cronologia

NASDAQ
SCNI
Scinai Immunotherapeutics
BIT
UC72MQ
Unicredit Bank
BOV
L1YG34M
Lloyds Banking
TSXV
WLF
Wolfden Resources
LSE
ROM
Romag Holdings
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network